Equities

Proteomics International Laboratories Ltd

Proteomics International Laboratories Ltd

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Proteomics International Laboratories Ltd's revenues fell -4.24% from 1.47m to 1.41m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 6.18m to a larger loss of 6.38m.
Gross margin--
Net profit margin-459.82%
Operating margin-457.63%
Return on assets-61.88%
Return on equity-71.67%
Return on investment-67.65%
More ▼

Cash flow in AUDView more

In 2024, Proteomics International Laboratories Ltd increased its cash reserves by 10.17%, or 612.92k. Cash Flow from Financing totalled 6.59m or 467.79% of revenues. In addition the company used 5.59m for operations while cash used for investing totalled 388.02k.
Cash flow per share-0.0457
Price/Cash flow per share--
Book value per share0.0719
Tangible book value per share0.0719
More ▼

Balance sheet in AUDView more

Proteomics International Laboratories Ltd has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 6.64m.
Current ratio10.13
Quick ratio--
Total debt/total equity0.0336
Total debt/total capital0.0331
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.